Advertisement
Short Report
High oral bioavailability of antimicrobial agents can result in the replacement of intravenous (IV) therapy with oral therapy when a patient meets defined clinical criteria. However, few studies have evaluated...
Journal of Pharmaceutical Policy and Practice 2016 9:35
Published on: 28 October 2016
Research
The increasing threat of antimicrobial resistance combined with the paucity of new classes of antibiotics represents a serious public health challenge. New treatment technologies could, in theory, have a signi...
Journal of Pharmaceutical Policy and Practice 2016 9:34
Published on: 26 October 2016
Editorial
The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between me...
Journal of Pharmaceutical Policy and Practice 2016 9:33
Published on: 25 October 2016
Research
Annual immunization is the most effective way to prevent influenza and its associated complications. However, optimal immunization rates are not being met in Nova Scotia, Canada. Additional providers, such as ...
Journal of Pharmaceutical Policy and Practice 2016 9:32
Published on: 19 October 2016
Review
The emergence and spread of antibiotic resistant pathogens poses a big challenge to policy-makers, who need to oversee the transformation of health systems that evolved to provide easy access to these drugs in...
Journal of Pharmaceutical Policy and Practice 2016 9:31
Published on: 7 October 2016
Research
Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation ...
Journal of Pharmaceutical Policy and Practice 2016 9:30
Published on: 6 October 2016
Research
The rising demand for chronic disease treatment and the barriers to accessing these medicines have led to the development of novel models for distributing medicines in South Africa’s public sector, including d...
Journal of Pharmaceutical Policy and Practice 2016 9:28
Published on: 1 October 2016
Review
Worldwide the demands on emergency and primary health care services are increasing. General practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor ailments...
Journal of Pharmaceutical Policy and Practice 2016 9:29
Published on: 29 September 2016
Research
Providing patient-centred care requires pharmacy students to learn how to interact effectively and understand individual differences that can influence patients’ health. The School of Pharmacy at The University o...
Journal of Pharmaceutical Policy and Practice 2016 9:24
Published on: 22 September 2016
Research
Medicines are a main therapeutic intervention provided within hospitals and their proper use in the outpatient setting is important for patients and the community. The objective of this study was to evaluate d...
Journal of Pharmaceutical Policy and Practice 2016 9:27
Published on: 22 September 2016
Commentary
The proposed Pharmacy Bill of Malaysia which served to consolidate and harmonise the existing pharmacy legislation which has been used for more than 60 years. This new Pharmacy Bill contains 17 parts and a tot...
Journal of Pharmaceutical Policy and Practice 2016 9:25
Published on: 22 September 2016
Review
The United States (U.S.) Food and Drug Administration, as protectors of public health, encourages generic drug development and use so that patients can access affordable medications. The FDA, however, has limi...
Journal of Pharmaceutical Policy and Practice 2016 9:26
Published on: 22 September 2016
Research
Prescription medicine sharing has been defined as the lending of medicines (giving prescription medicines to someone else) or borrowing of medicines (being given and using a medicine prescribed for another per...
Journal of Pharmaceutical Policy and Practice 2016 9:23
Published on: 9 September 2016
Research
Lack of access to insulin and poor health outcomes are issues for both low and high income countries. This has been accompanied by a shift from relatively inexpensive human insulin to its more expensive analog...
Journal of Pharmaceutical Policy and Practice 2016 10:3
Published on: 19 July 2016
Research
Pharmacists in Japan currently play a key role in patient hospital care. Their responsibilities include filling prescriptions, checking a patient’s medication history, and providing appropriate information to ...
Journal of Pharmaceutical Policy and Practice 2016 10:2
Published on: 19 July 2016
Research
Due to the lack of clear, comprehensive, and rational drug policy, the production of pharmaceutical preparations in India is distorted for the most part. Indian markets are flooded with more than 70,000 formul...
Journal of Pharmaceutical Policy and Practice 2016 10:1
Published on: 19 July 2016
Research
The Integrated Management of Childhood Illnesses is the main approach for treating children in more than 100 low income countries worldwide. In 2007, the World Health Assembly urged countries to integrate ‘bet...
Journal of Pharmaceutical Policy and Practice 2016 9:22
Published on: 7 June 2016
Research
Uganda introduced a multipronged intervention, the supervision, performance assessment, and recognition strategy (SPARS), to improve medicines management (MM) in public and not-for-profit health facilities. Th...
Journal of Pharmaceutical Policy and Practice 2016 9:21
Published on: 31 May 2016
Research
In 2014, a qualitative multi-country research project was launched to study the reasons behind the high use of antibiotics in regions of Southeast Europe by using previously untrained national interviewers (wh...
Journal of Pharmaceutical Policy and Practice 2016 9:20
Published on: 23 May 2016
Editorial
This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the a...
Journal of Pharmaceutical Policy and Practice 2016 9:19
Published on: 6 May 2016
Research
Since its inception, the Uganda National Drug Authority (NDA) has regularly inspected private sector pharmacies to monitor adherence to Good Pharmacy Practices (GPP). This study reports findings from the first...
Journal of Pharmaceutical Policy and Practice 2016 9:18
Published on: 4 May 2016
Research
India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India’s pharmaceutica...
Journal of Pharmaceutical Policy and Practice 2016 9:16
Published on: 2 May 2016
Letter to the Editor
Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has foc...
Journal of Pharmaceutical Policy and Practice 2016 9:15
Published on: 2 May 2016
Research
Consumers are hesitant in choosing generic medications as they are under the assumption that they are not as safe nor effective as brand medications. However, pharmacists do have the education and training to ...
Journal of Pharmaceutical Policy and Practice 2016 9:17
Published on: 21 April 2016
Commentary
Achieving increased access to medicines in low- and middle-income countries is a complex issue that requires a holistic approach. Choosing an appropriate manufacturing strategy that can ensure a sustainable su...
Journal of Pharmaceutical Policy and Practice 2016 9:14
Published on: 8 April 2016
